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Ultraviolet-radiation suppresses cell-mediated immunity in healthy humans. It has been postulated that, in the
short term, this immunosuppression prevents autoimmune responses to ultraviolet-radiation damaged skin.
Patients with polymorphic light eruption (PLE) demonstrate abnormal responses to ultraviolet-radiation suggestive
of an immune response to an ultraviolet-radiation-induced antigen. We investigated whether PLE patients (n=22)
were resistant to ultraviolet-radiation-induced immunosuppression compared to skin-type, aged-matched controls
(n=23). Groups of patients and controls (six subjects per group) received a single dose of solar-simulated
ultraviolet-radiation of either 0, 0.6, 1 or 2 minimal erythema doses (MED). Erythema was quantiﬁed using a
reﬂectance meter and all volunteers were sensitised on the irradiated site with dinitrochlorobenzene. Contact
hypersensitivity responses (CHS) to dinitrochlorobenzene were quantiﬁed after challenge using ultrasound.
Ultraviolet-radiation-induced erythema was comparable in patients and controls. CHS was comparable in
unirradiated patients and controls. UVR-induced a dose-dependent suppression of CHS in all volunteers but
patients were more resistant to immunosuppression after 1MED. Exposure to 1MED suppressed CHS by 78% in
controls but induced less suppression in patients (44%, p o 0.01). Our data suggest that PLE patients have a ﬂaw
in their immunoregulatory response to ultraviolet-radiation it is only apparent over a narrow dose range around
1 MED.
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Polymorphic light eruption (PLE) is the most common of the
so-called ‘‘idiopathic’’ photodermatoses, affecting 15% of
healthy people in the UK (Pao et al, 1994). PLE is
characterized by a delayed abnormal reaction to sunlight
consisting of transient, nonscarring pruritic papules and
vesicles, typically developing hours or days after sun
exposure and resolving over several days without sequelae.
The pathogenesis of PLE is unclear, but histologic studies
suggest that an abnormal T-cell-mediated immunologic
response is involved (Norris and Hawk, 1990).
It is well established that the ultraviolet component of
sunlight ([UVR]  295–400 nm) suppresses cutaneous T-
cell-mediated immunity in humans. Depletion of Langerhans
cells, the principal antigen-presenting cells in the epidermis,
recruitment of macrophages into the dermis and epidermis,
and release of cytokines, in particular tumor necrosis factor
a (TNF-a) and interleukin-10 (IL-10), are all important events
in the initiation of UVR-induced immune suppression. These
changes result in an alteration in antigen presentation
leading to the generation of regulatory cells that inhibit
cell-mediated immune responses to newly encountered
antigens (reviewed by Norval, 2001). The immunopathology
of UVR-exposed skin in PLE provides circumstantial
evidence of a defect in the induction of immune suppres-
sion after UVR exposure. Ko¨lgen et al (1999) have
demonstrated that single UVR exposures, which did not
induce lesions in PLE patients, were associated with a
persistence of epidermal Langerhans cells and the recruit-
ment of a different macrophage subset compared to normal
skin. Similarly in PLE lesions UVR does not deplete
epidermal Langerhans cells but provokes endothelial adhe-
sion molecule expression and a T-cell-rich infiltrate similar
to that normally seen during an allergic contact hypersensi-
tivity (CHS) response (Norris et al, 1989, 1992). In vitro data
have also shown that UVR exposure increases epidermal
cell capacity to stimulate autologous peripheral blood
mononuclear cells in PLE patients but not normal volunteers
(Gonzalez-Amaro et al, 1991), implying that T cells in the
peripheral blood of PLE patients recognize UVR-induced
antigens on epidermal cells. Thus it is widely believed that
PLE is provoked by a T-cell-mediated response against a
cutaneous UVR-induced antigen.
Abbreviations: CHS, contact hypersersitivity; PLE, polymophic
light eruption; UVR, ultraviolet radiation.
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In this study we have tested the hypothesis, as also
suggested by Ko¨lgen et al (1991), that in PLE patients the
normal UVR-induced suppression of cell-mediated immu-
nity is impaired and as a result these patients develop a
T-cell-mediated response to a UVR-activated antigen
(photoantigen).
Cell-mediated immunity was tested in patients and age-
and skin-type-matched controls by quantitative assessment
of CHS response, induced by topical application of the
chemical hapten 2,4-dinitrochlorobenzene (DNCB) to the
skin.
Results
Single exposures to UVR induced comparable erythema
responses in PLE patients and controls but did not
induce PLE lesions
Visual assessments The MED range for PLE patients was
within the range of normal healthy age- and skin-type-
matched controls. The distribution of MED for each
treatment group is summarized in Table I. UVR exposure
did not induce PLE lesions in any of the volunteers either on
the MED test series sites or on the 5  5 cm test site that
was used to sensitize the volunteers to DNCB.
Quantitative assessments For the MED series sites, ex-
posure to UVR induced a dose-dependent increase in
erythema in both PLE patients and controls. The mean
slope of the erythema dose–response curves was 18.7
erythema units per J per cm2 (CI 15.1–22.3) for PLE patients
and 22.0 erythema units per J per cm2 (CI 18.4–25.6) for
controls with no significant difference in the slope of the
respective erythema dose–response curves (p¼ 0.20).
For the 5  5 cm test sites, where the volunteers were
subsequently sensitized to DNCB, no significant difference
was observed in the intensity of erythema 24 h after
exposure to either 0.6, 1, or 2 MED between PLE patients
and controls (Fig 1).
PLE patients were more resistant to UVR-induced
suppression of CHS than controls after a mild sunburn
(1 MED) but not after a vivid sunburn (2 MED)
Unirradiated volunteers All unirradiated volunteers in both
the patient and control groups were successfully sensitized
and developed a DNCB dose-dependent CHS response to
all four incremental challenge doses of DNCB. There was no
significant difference in the CHS response of these two
groups (p¼ 0.8).
UVR-exposed volunteers Exposure to UVR induced a
dose-dependent suppression of CHS in PLE patients and
controls (Fig 2). A moderate but vivid sunburn (2 MED)
almost completely suppressed CHS in both patients and
controls (93%). At 1 MED controls were more suppressed
than PLE patients, 78% vs 44% (po0.01; 95% CI 6–62).
Suppression of CHS was also greater after 0.6 MED in
controls than PLE patients (43% vs 31%) but this was not
statistically significant (p¼ 0.5).
Discussion
The aim of this study was to compare the relationship
between UVR-induced erythema and immunosuppression
in PLE patients of a defined skin-type (I/II). At present there
are no functional studies of UVR-induced suppression of
cell-mediated immunity in PLE patients and there is also
Table I. Volunteer demographics
Group Controls PLE patients
UVR exposure (MED) 0 0.6 1 2 0 0.6 1 2
Skin type 5 II 2 I 1 I 1 I 2 I 2 I 3 I 2 I
1 II/III 2 II 3 II 2 II 3 II 2 II 3 II 2 II
1 I/II 2 I/II 3 II/III 1 II/III 1 II/III
1 III
Gender 4 f 5 f 5 f 3 f 4 f 3 f 6 f 6 f
2 m 1 m 3 m 2 m 1 m
Agea 31 32 38 34 36 36 45 48
(21–35) (19–39) (25–47) (20–38) (27–46) (31–44) (35–50) (32–52)
MED (J per cm2)b 6.4 4.3 4.8 4.3 3.4 3.9 3.4 5.4
(5.1–7.9) (4.0–7.9) (3.4–6.3) (2.7–5.4) (2.2–5.4) (2.7–4.3) (2.7–4.3) (2.7–6.7)
MED (J per cm2)c 6.2 5.1 4.8 4.4 4.1 3.7 3.6 5.0
(5.1–7.3) (3.0–7.1) (3.7–6.0) (3.4–5.4) (2.9–5.3) (2.4–4.9) (2.9–4.2) (3.6–6.4)
aAge expressed as median (range).
bJust perceptible median MED (range) expressed as total UVR dose (290–400 nm).
cJust perceptible mean MED (95% CI) expressed as total UVR dose (290–400 nm). Note that the differences in MED between patients and controls
were not significant (p40.1) in the 0.6 and 2 MED groups but were significant (po0.01; p¼ 0.04) in the 0 and 1 MED groups.
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some conflict as to whether they do (Ko¨lgen et al, 1999;
Boonstra et al, 2000) or do not (Diffey and Farr, 1986;
Mastalier et al, 1998) have a lower MED threshold than
normal controls. Ethical considerations prompted us to
design the experiments using erythemally weighted UVR
doses (multiples of MED), rather than a set scale of physical
UVR doses, to ensure that no volunteer received a severe
(blistering) sunburn. The MED range of our PLE patients,
determined visually, was within that expected for healthy
skin types I/II (Table I). Quantitative assessments of the
degree of erythema, determined using reflectance spectro-
scopy, also showed that erythema responses were similar in
both groups. The intensity of erythema was comparable
after an equivalent MED exposure (Fig 1) and over the
physical UVR dose range used for MED determination.
This supports data from Diffey and Farr (1986) who
reported that the erythema dose–response curves for UVB
and UVC in PLE patients were indistinguishable from
controls.
We also found that the CHS responses of unirradiated
PLE patients were identical to controls (p¼0.8) and
exposure to solar simulated UVR induced a dose-depen-
dent suppression of CHS in both groups, leading to almost
complete immunosuppression (93%) after 2 MED. PLE
patients, however, were substantially less suppressed than
controls after 1 MED (44% and 78%, respectively, po0.01).
Less suppression was also seen in PLE patients after 0.6
MED but this did not reach significance (p¼ 0.5) (Fig 2). Our
results suggest that PLE patients may be resistant to UVR-
induced immunosuppression compared to controls but we
need to be cautious in interpreting the results. It is possible
that PLE patients were less immunosuppressed after a 1
MED exposure simply because the physical dose of UVR
required to induce erythema in PLE patients was slightly
lower than controls: 3.6 J per cm2 and 4.8 J per cm2,
respectively (p¼ 0.04; 95% CI 0.08–2.39) (Table I). The
dose–response for immunosuppression is quite steep
between 0.6 and 1 MED, so a small difference in physical
dose may have confounded the results. If PLE patients are
resistant to suppression of CHS compared to controls then
a further study with a larger number of patients is required
to confirm our findings. At present, our data suggest that
resistance to immunosuppression is only apparent over a
modest dose range (around 1 MED) and can be overcome if
higher UVR doses are given. This may explain why PLE
lesions are provoked by low UVR exposures but are rarely
observed after a severe sunburn.
Although our data imply that PLE patients have a flaw in
their immunoregulatory response to UVR exposure and
would seem to support those of Ko¨lgen et al (1999), there
are important differences between our functional data and
Ko¨lgen’s histologic findings. First, in Ko¨lgen’s study, a high
dose of nonsolar UVR (6 MED) depleted epidermal
Langerhans cells in healthy controls and led to the
recruitment of dermal CD11bþ /CD68– macrophage-like
cells. In PLE patients, epidermal Langerhans cells were
retained and the infiltrating macrophage-like cells were
CD11bþ /CD68þ , implying that PLE patients are resistant to
immunosuppression after a high dose of UVR. In contrast,
we find that the highest UVR dose used in our study (2 MED)
is highly immunosuppressive in both patients and controls
(Fig 2). Furthermore, our previous studies have also shown
that single exposures of 0.75 MED or 1 MED of solar
simulated UVR do not significantly deplete epidermal
Langerhans cells in healthy human subjects (Novakovic
et al, 2001), and so a retention of epidermal Langerhans
cells in our PLE patients would not explain their resistance
to suppression of CHS (dermal macrophages were not
assessed). Our group has also reported that Langerhans
cells are present in the epidermis of UVR-provoked PLE
lesions (Norris et al, 1989) but the time-course data from
this study suggested that they migrated from the dermis
after irradiation. Ko¨lgen et al (1999) took biopsies at a single
time point after UVR (48 h) so it is not clear if they are
observing a retention or recruitment of Langerhans cells.
Further work is under way in our laboratories to clarify this
point and to establish if an aberrant infiltration of CD11bþ /
Figure 1
UVR-induced erythema responses were comparable in PLE
patients and controls after an equivalent MED challenge. Erythema
was quantified using a reflectance meter (Diastron) as described in
Materials and Methods. The mean increase in erythema (erythema
index þ SD) for each UVR treatment group is shown. There was no
significant difference in the intensity of erythema between PLE patients
(’) and age- and skin-type-matched controls (&) 24 h after exposure
to 0.6 MED (p40.4), 1 MED (p40.17) or 2 MED (p40.37).
Figure 2
PLE patients were more resistant to immunosuppression than
controls after a mild sunburn (1 MED), but a vivid sunburn (2 MED)
almost completely suppressed both groups. The percentage
suppression of CHS was calculated as described in Materials and
Methods. The figures in parentheses represent percentage suppression
of CHS and are the means  SEM. After 1 MED, controls were more
suppressed than PLE patients (po0.01; 95% CI 6–62). Suppression
was also greater after 0.6 MED in controls but this was not statistically
significant (p¼0.5). All volunteers were substantially suppressed after
2 MED.
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CD68þ macrophage-like cells occurs in PLE after exposure
to low dose solar UVR.
It is also important to note that we did not observe PLE
lesions in any of our patients after single exposures to solar
simulated UVR, a finding also reported in Ko¨lgen’s study.
The most likely explanation for this is that all irradiations
were on previously unexposed buttock skin. Our group has
reported that lesions can be provoked by single exposures
to low dose solar simulated UVR on previously sun-exposed
sites (Norris et al, 1989) but we find that it usually requires
three exposures to low doses (0.25–1.5 MED) of solar
simulated UVR to induce lesions on buttock skin. We also
find that successful provocation of PLE is dependent upon
erythemally weighted UVR exposure (MED) and not
cumulative physical UVR dose (J per cm2) (van de Pas
et al, 2004), perhaps implying that resistance to immuno-
suppression in the presence of mild inflammation is
important in the pathogenesis of PLE. If, however, resis-
tance to immunosuppression plays a role in disease
expression it is probably not the only cutaneous abnorm-
ality. In our previous studies of healthy volunteers we found
that skin types III/IV were 2-fold more resistant to UVR-
induced suppression of CHS than skin types I/II for a given
MED, and 5-fold more resistant for a given physical UVR
dose (Kelly et al, 2000). None of these volunteers had a
history of PLE, demonstrating that resistance to UVR-
induced immunosuppression on its own does not give rise
to PLE lesions. One explanation may be that the putative
photoantigen in PLE is not commonly expressed or is
rapidly cleared from the UVR-exposed skin of healthy
controls. Heat shock protein 65 is elevated in PLE lesions
(McFadden et al, 1994), but not in UVR-exposed skin from
healthy controls, and is a possible photoantigen. So far no
other studies have attempted to identify the nature of the
photoantigen(s) in these patients. At present any investiga-
tions into possible flaws in immunoregulation in PLE are
hampered by the limited data on normal responses to UVR
in healthy humans. Much work is needed not only on the
mechanisms and genetics of susceptibility factors to
immunosuppression but also on wavelength dependence
and modulation of immune function by multiple UVR
exposures.
In conclusion, our study suggests that PLE patients may
have a failure in immunoregulation after a mild sunburn (1
MED). We hypothesize that this resistance to UVR-induced
suppression of cell-mediated immunity may lead to a T-cell-
mediated response to a photoantigen but further work with
a larger group of patients is needed to confirm these
findings. Evidence is also required to link the appearance of
lesions (multiple UVR exposures) with the induction of
immunosuppression (single UVR exposure).
Materials and Methods
Volunteers Twenty-three white-skinned Caucasian patients (age
range 19–52 y) who were diagnosed with PLE at the Photobiology
Clinic of St John’s Institute of Dermatology were randomly
recruited into the study. Diagnosis was made on the basis of
clinical history and examination, supported by monochromatic
irradiation and solar simulated provocation tests as deemed
clinically relevant. The condition was defined as a fully resolving,
papular, photo-eruption occurring 1–48 h after sun exposure.
Patients were screened to exclude lupus by estimation of their
antinuclear and extractable nuclear antigen autoantibodies and
porphyria by blood, urine, and stool porphyrin levels. Skin type
was assessed by interview and erythema assessment. Twenty-
three skin-type- and age-matched normal healthy controls, who
had no history of photosensitivity, were also recruited into the
study from staff and students working at St Thomas’ Hospital. Only
one volunteer (PLE patient) failed to complete the study.
Exclusion criteria for all volunteers, during or in the 6 mo prior to
the study, included phototherapy, medication (oral contraceptive
excepted), previous exposure of buttock skin (test site) to
sunlamps or sunlight, a recent sunburn, or previous exposure
to the contact allergen DNCB. Pregnant or lactating females
were also excluded as were outdoor workers and people who
participated in regular outdoor sport. The study was approved by
the local ethical committee and adhered to the Declaration of
Helsinki guidelines for use of human subjects. Each volunteer was
fully informed of the procedures and gave written informed consent
to participate. The volunteers’ demographics are summarized in
Table I.
UVR source and dosimetry Solar simulated UVR was generated
by a 1 kW xenon arc solar simulator (Oriel, Stratford, CT) fitted with
a WG320 1 mm thick glass filter, giving an even field of irradiance
(290–400 nm) of about 15 mW per cm2 on the skin surface at 11 cm
from the source. Irradiance was routinely determined with a wide-
band thermopile radiometer (Medical Physics, Dryburn Hospital,
Durham, UK) calibrated against a DM150 double monochromator
Bentham spectroradiometer (Bentham Instruments, Reading, UK).
Eighty-eight percent of the erythemally effective energy of the
source was in the UVB range with the remaining 12% in the UVA.
Irradiation protocol The minimal dose of UVR required to induce
a just visibly perceptible erythema at 24 h (minimal erythema dose,
MED) was determined on the buttock skin of each volunteer using
a geometric series of eight exposure doses with increments of 1.25
(dose range 1.1–10.5 J per cm2). Quantitative measurements of
erythema intensity were also made in triplicate, 24 h after UVR
exposure, using a reflectance meter (Diastron, Andover, UK). For
each individual, the increase in erythema (erythema index) on each
UVR-exposed site was calculated by subtracting the mean
background reading of adjacent nonirradiated skin. The erythema
index was plotted against physical UVR dose (J per cm2) and the
erythema response was represented by the slope of the linear
regression line.
One week later, PLE patients were randomly assigned to
different UVR treatment groups (n¼ 6). Healthy controls were also
recruited to UVR treatment groups to match the age and skin type
of the patients. Each volunteer received a single UVR exposure on
a 5  5 cm site on the buttock of either 0, 0.6, 1.0, or 2.0 MED.
Quantitative measurements of erythema intensity were made 24 h
after UVR exposure, as described above. The erythema response
of each individual was represented by the mean erythema index of
the irradiated site.
Induction and quantiﬁcation of CHS response Full details of the
sensitization and elicitation protocols are given elsewhere (Kelly
et al, 1998). Briefly, volunteers were sensitized via buttock skin
using a 12 mm Finn chamber containing 50 mL of 0.0625% DNCB
in ethanol (31.2 mg per 50 mL).
Three weeks after sensitization, volunteers were challenged on
the UVR-protected upper inner arm using five 8 mm Finn
chambers: one contained ethanol only and four contained
incremental doses of DNCB (3.125, 6.25, 12.5, and 25.0 mg per
20 mL). The elicitation sites were marked on the arm with a surgical
skin marker. The chambers were taped in place for 48 h. Elicitation
responses were quantified by measuring dermal thickness im-
mediately before and 72 h after challenge using a high frequency
ultrasound scanner (Quality Medical Instruments, Silchester, Read-
ing, UK) and the percentage increase in dermal thickness was then
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determined as follows:
dermal thickness at 72h dermal thickness at 0 h
dermal thickness at 0 h
 
 100%
The percentage increase in dermal thickness for each elicitation
site was plotted versus DNCB challenge dose (x axis), and the
dose–response relationship was determined using linear regres-
sion analysis. The CHS response of a given individual is
represented by the slope of the linear regression line—the steeper
the slope, the stronger the response (Kelly et al, 1998).
Calculation of UVR-induced immunosuppression The slope of
the elicitation response for each of the UVR-treated individuals was
also used in the formula below to calculate percentage suppres-
sion of CHS:
1 slope of elicitation response in IR subject
mean slope of elicitation response in UR group
  
 100%
where IR stands for irradiated and UR stands for unirradiated.
Statistical methods Erythema responses in patients and controls
were compared using quantitative data measured with the
reflectance meter from (1) the nine sites used to determine each
individual’s MED, where erythema response was estimated for
each individual by regression of erythema index against physical
UVR dose (J per cm2); and (2) the 5  5 cm test sites used for
sensitization using four groups of eight individuals exposed to a
single erythemally weighted UVR exposure (multiple of MED; Fig
1). For both studies, 23 observations were available on PLE
patients and 20 on controls.
The percentage suppression of CHS was determined for each
individual as described above using four groups of eight individuals
exposed to a single erythemally weighted UVR exposure (Fig 2).
Twenty-two observations were available on PLE patients and 23 on
controls.
All calculations were carried out using Microsoft Excel 2000.
Comparisons of erythema and percentage suppression of CHS
responses in patients and controls were compared using unpaired
Student’s t tests. Results are expressed as estimates with 95%
confidence intervals (CI) and p values. Significance is assumed
when po0.05.
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